Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuromuscular
Biotech
Novartis pays $500M for neuroscience-focused DTx
Should the three programs develop as planned, DTx will be eligible to double its money thanks to up $500 million in milestone payments.
James Waldron
Jul 17, 2023 10:10am
Astellas takes another punt at tricky muscular condition
Jun 8, 2023 9:20am
Rona buys siRNA platform, 4 preclinical liver drugs from Sanofi
Jul 25, 2022 8:41am
Biohaven to take a chance on BMS' once-failed DMD med
Feb 25, 2022 10:49am
NMD pulls in $40M from Jeito-led, Roche-backed syndicate
Feb 15, 2022 7:10am
Sarepta, GenEdit ink $57M collab for neuromuscular gene editing
Feb 1, 2022 8:00am
